Lexaria Bioscience Corp. financial data

Symbol
LEXX, LEXXW on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 740 Mccurdy Road, Kelowna, British Columbia, Canada
State of incorporation
NV
Fiscal year end
August 31
Former names
Lexaria Corp. (to 5/11/2016), LEXARIA CORP. (to 5/11/2016)
Latest financial report
10-K - Q3 2024 - Nov 26, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.72K % +99.4%
Quick Ratio 0.96 % -94.4%
Debt-to-equity 6.82 % -39.5%
Return On Equity -86.1 % +44.2%
Return On Assets -80.3 % +41.6%
Operating Margin -1.24K % +57.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.5M shares +67.2%
Common Stock, Shares, Outstanding 15.8M shares +95.4%
Entity Public Float 40.6M USD
Common Stock, Value, Issued 15.8K USD +95.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 464K USD +105%
Revenue from Contract with Customer, Excluding Assessed Tax 151K USD +54.8%
Research and Development Expense 2.36M USD -35.6%
General and Administrative Expense 3.85M USD +25.8%
Operating Income (Loss) -5.75M USD +12%
Net Income (Loss) Attributable to Parent -5.8M USD +13%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.27M USD -60.9%
Marketable Securities, Current 55.8K USD -55.6%
Accounts Receivable, after Allowance for Credit Loss, Current 154K USD +21.9%
Inventory, Net 0 USD -100%
Assets, Current 7.9M USD +267%
Property, Plant and Equipment, Net 255K USD +0.22%
Operating Lease, Right-of-Use Asset 143K USD
Assets 8.87M USD +188%
Liabilities, Current 1.1M USD +311%
Operating Lease, Liability, Noncurrent 18.3K USD -69.5%
Liabilities 1.21M USD +199%
Accumulated Other Comprehensive Income (Loss), Net of Tax -19.8K USD
Retained Earnings (Accumulated Deficit) -51.6M USD -12.7%
Stockholders' Equity Attributable to Parent 8.04M USD +164%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 7.66M USD +186%
Liabilities and Equity 8.87M USD +188%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.18M USD +5.11%
Net Cash Provided by (Used in) Financing Activities 1.82M USD
Net Cash Provided by (Used in) Investing Activities -40K USD -14.9%
Common Stock, Shares Authorized 220M shares 0%
Common Stock, Shares, Issued 15.8M shares +95.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 602K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.5M USD +381%
Deferred Tax Assets, Valuation Allowance 10.7M USD +12%
Deferred Tax Assets, Gross 10.7M USD +12%
Operating Lease, Liability 143K USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.82M USD +12.7%
Lessee, Operating Lease, Liability, to be Paid 160K USD -17.6%
Operating Lease, Liability, Current 41.8K USD +8.68%
Lessee, Operating Lease, Liability, to be Paid, Year Two 37.1K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 0 USD -100%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 37.3K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38.6K USD 0%
Operating Lease, Payments 8.96K USD -80%
Additional Paid in Capital 59.6M USD +22.1%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 170K USD